# Andapharm, LLC, Fort Lauderdale, FL – FDA Inspections

Source: https://www.keypedia.com/companies/andapharm-llc/62711f7a-0996-4623-93e4-87351349e6c9

> Inspection records and compliance data for Andapharm, LLC in Fort Lauderdale, Florida. 4 FDA inspections on record (1 OAI), 1 Form 483, 2 warning letters, last inspected July 18, 2018.

---

## Details

- Name: Andapharm, LLC
- FEI Number: 3005000348
- Business Operations: FDF MANUFACTURE, PACK
- Address Line 1: 5315 Nw 35th Ter
- City: Fort Lauderdale
- State: Florida
- Zip Code: 33309
- Country Name: United States
- Address: 5315 Nw 35th Ter, Fort Lauderdale, Florida 33309, United States
- Country: United States

## Related Documents

- [WARNING_LETTER - Andapharm, LLC - 2018-07-18](https://www.keypedia.com/records/warning_letter/andapharm-llc/3dac399d-3df7-42e4-8f8b-76a60dc787c6) — source: FDA, date: July 18, 2018
- [FDA Inspection 1059714 - Andapharm, LLC - 2018-07-18](https://www.keypedia.com/records/fda_inspections/andapharm-llc/df2941b0-2e30-4a14-ac3b-8191f03554a9) — classification: Official Action Indicated (OAI), source: FDA, date: July 18, 2018
- FDA Inspection 961715 - Andapharm, LLC - 2016-02-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 26, 2016
- [FDA Inspection 961715 - Andapharm, LLC - 2016-02-26](https://www.keypedia.com/records/fda_inspections/andapharm-llc/e7fe3687-2e68-4da7-9ad7-8a3d9a783308) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 26, 2016
- [WARNING_LETTER - Andapharm, LLC - 2014-10-10](https://www.keypedia.com/records/warning_letter/andapharm-llc/782ad040-ec55-4999-a423-0e376ae0939d) — source: FDA, date: October 10, 2014
- [FDA Inspection 764765 - Andapharm, LLC - 2012-02-07](https://www.keypedia.com/records/fda_inspections/andapharm-llc/89f52d14-491f-42ee-a275-4b2d73793cbd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2012
- FDA Inspection 602314 - Andapharm, LLC - 2009-08-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 7, 2009

## Related Companies

- [Rpk Pharmaceuticals Inc](https://www.keypedia.com/companies/rpk-pharmaceuticals-inc/4fcc57aa-1dbd-44d8-859b-3754c50751af)
- [Vantage Specialty Ingredients](https://www.keypedia.com/companies/vantage-specialty-ingredients/61ceb95e-844d-4b4b-a2e9-cf927d214d27)
- [NuSil Technology LLC](https://www.keypedia.com/companies/nusil-technology-llc/ef176ca7-d941-4939-89a4-be78633f5cb4)
- [John D. Gabriel, MD](https://www.keypedia.com/companies/john-d-gabriel-md/6c8dab33-f0fe-48ec-8b27-7c62dededa1f)
- [Dr. Reddy's Laboratories, Inc.](https://www.keypedia.com/companies/dr-reddys-laboratories-inc/ec3847d0-42b8-478b-bb7e-5e986389f184)
- [Nationwide Laboratories, LLC](https://www.keypedia.com/companies/nationwide-laboratories-llc/e5dccf31-f7a6-4a51-9f59-7e2929127933)
- [Shishuka Malhotra MD](https://www.keypedia.com/companies/shishuka-malhotra-md/01b66b3a-180c-4784-8210-0d1454be1832)
- [Mirum Pharmaceuticals, Inc.](https://www.keypedia.com/companies/mirum-pharmaceuticals-inc/9b906e94-ef88-467f-8b15-9f0b02d9e49d)
- [Hagop M. Kantarjian, M.D.](https://www.keypedia.com/companies/hagop-m-kantarjian-md/57a20198-e024-409a-b67e-d0b49222c3a9)
- [Joseph L. Lillo, D.O.](https://www.keypedia.com/companies/joseph-l-lillo-do/1ea0d267-f3a4-4b8f-9611-61ba95abc6b1)

## Related Officers

- [Michael M. Levy](https://www.keypedia.com/people/michael-m-levy/3e0fdd21-e691-406d-81cf-4fe2460a6309)
- [Program Division Director](https://www.keypedia.com/people/monica-r-maxwell/e1b3373a-80b0-4023-9aea-b4ac7170c964)
- [Renee Alsobrook](https://www.keypedia.com/people/renee-alsobrook/2ecfa488-4a0e-46bd-af85-a5a43456f225)
